Variant · Snv
RET NM_020975.6(RET):c.422G>C (p.Gly141Ala)
CI-VAR-00171898Explore in graph →p.Gly141AlaNM_020975.6:c.422G>CClinVar 1002252 rs770840152
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1002252 | Uncertain significance | criteria provided, multiple submitters, no conflicts | 2 | Multiple endocrine neoplasia, type 2; Hereditary cancer-predisposing syndrome; Familial medullary thyroid carcinoma; Multiple endocrine neoplasia type 2B; Hirschsprung disease, susceptibility to, 1; Multiple endocrine neoplasia type 2A; Pheochromocytoma | germline | 3 | Apr 13, 2025 | clinvar |